Skip to main content
SpringerLink
Log in

Advances in the treatment of cervical cancer

  • Chapter
Gynecologic Oncology

Part of the book series: Cancer Treatment and Research ((CTAR,volume 95))

Abstract

Worldwide, cervical cancer is the second most common malignancy among women, with approximately 437,000 new cases each year, and is the second leading cause of cancer death [1]. Approximately three fourths of the cases occur in developing countries, where it is the leading cause of cancer mortality. In the United States there will be an estimated 15,700 new cases of cervical cancer in 1996, leading to 4900 deaths [2]. Among African-American women, cervical cancer is the fourth most common cancer, with 2300 new cases and 1100 deaths each year [3]. In virtually every geographic region of the world where cytologic screening programs have been established, the incidence and mortality rates from cervical cancer have been drastically reduced; however, mortality from invasive cancers of the cervix has not been eliminated. The majority of women who die from this disease are poor, elderly, or indigent, and either do not have access to or participate in established screening programs. Until the access to medical care problem is resolved, invasive cervical cancer will remain a significant cause of morbidity and mortality among the female population.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 429.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 549.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 549.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Parkin DM, Pisani P, Ferlay J (1993) Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594–606.

    Article  PubMed  CAS  Google Scholar 

  2. Parker SL, Tong T, Bolden S, Wingo PA (1996) Cancer statistics, 1996. CA Cancer J Clin 46:5–27.

    Article  PubMed  CAS  Google Scholar 

  3. Wingo PA, Bolden S, Tong T, Parker SL, Martin LM, Heath CW (1996) Cancer statistics for African Americans, 1996. CA Cancer J Clin 46:113–125.

    Article  PubMed  CAS  Google Scholar 

  4. Clark JG (1895) A more radical method of performing hysterectomy for cancer of the uterus. Johns Hopk Hosp Bull 52-53:120–128.

    Google Scholar 

  5. Mikuta JJ (1996) Historical development of radical surgery for cancer of the cervix. In: Rubin SC, Hoskins WJ, eds. Cervical Cancer and Preinvasive Neoplasia. New York: Lippincott-Raven, pp. 183–188.

    Google Scholar 

  6. Wertheim E (1905) A discussion on the diagnosis and treatment of cancer of the uterus. Br Med J 2:689–704.

    Article  Google Scholar 

  7. Liu W, Meigs JV (1955) Radical hysterectomy and pelvic lymphadenectomy: A review of 473 cases including 244 for primary invasive carcinoma of the cervix. Am J Obstet Gynecol 69:1–32.

    PubMed  CAS  Google Scholar 

  8. Shingleton HM, Orr JW Jr. (1995) Primary surgical treatment of cancer of the cervix. In: Cancer of the Cervix, 2nd ed. Philadelphia: B Lippincott, pp. 124–154.

    Google Scholar 

  9. Ciatto S, Pirtoli L, Cionini L (1980) Radiotherapy for postoperative failures of carcinoma of the cervix uteri. Surg Gynecol Obstet 151:621–624.

    PubMed  CAS  Google Scholar 

  10. Tan R, Chung CH, Liu MT, Lai YL, Chang KH (1991) Radiotherapy for postoperative recurrent uterine cervical carcinoma. Acta Oncol 30:353–355.

    Article  PubMed  CAS  Google Scholar 

  11. DiSaia PJ (1981) Surgical aspects of cervical carcinoma. Cancer 48:548–559.

    Article  PubMed  CAS  Google Scholar 

  12. Burghardt E, Pickel H (1978) Local spread and lymph node involvement in cervical cancer. Obstet Gynecol 52:138–145.

    PubMed  CAS  Google Scholar 

  13. Baltzer J, Lohe KJ, Kopeke W, Zander J (1982) Histologic criteria for the prognosis in patients with operated squamous cell carcinoma of the cervix. Gynecol Oncol 13:184–194.

    Article  PubMed  CAS  Google Scholar 

  14. Burghardt E, Girardi F, Lahousen M, et al. (1991) Microinvasive carcinoma of the uterine cervix (International Federation of Gynecology and Obstetrics stage IA). Cancer 67:1037–1045.

    Article  PubMed  CAS  Google Scholar 

  15. Piver MS, Chung WS (1975) Prognostic significance of cervical lesion size and pelvic lymph node metastases in cervical carcinoma. Obstet Gynecol 46:507–510.

    PubMed  CAS  Google Scholar 

  16. Alvarez RD, Soong SJ, Kinney WK, et al. (1989) Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix. Gynecol Oncol 35:130–135.

    Article  PubMed  CAS  Google Scholar 

  17. Delgado G, Bundy BN, Fowler WC Jr., et al. (1989) A prospective surgical pathological study of stage I squamous carcinoma of the cervix: A Gynecologic Oncology Group study. Gynecol Oncol 35:314–320.

    Article  PubMed  CAS  Google Scholar 

  18. Zaino RJ, Ward S, Delgado G, et al. (1992) Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study. Cancer 69:1750–1758.

    Article  PubMed  CAS  Google Scholar 

  19. van Nagell JR Jr., Donaldson ES, Wood EG, et al. (1978) The significance of vascular invasion and lymphocytic infiltration in invasive cervical cancer. Cancer 41:228–234.

    Article  PubMed  Google Scholar 

  20. Barber HRK, Sommers SC, Rotterdam H, et al. (1978) Vascular invasion as a prognostic factor in stage IB cancer of the cervix. Obstet Gynecol 52:343–348.

    PubMed  CAS  Google Scholar 

  21. Averette HG, Nelson JH Jr., Ng ABP, et al. (1976) Diagnosis and management of microinvasive (stage IA) carcinoma of the uterine cervix. Cancer 38:414–425.

    Article  PubMed  CAS  Google Scholar 

  22. van Nagell JR Jr., Greenwell N, Powell DF, et al. (1983) Microinvasive carcinoma of the cervix. Am J Obstet Gynecol 145:981–989.

    PubMed  Google Scholar 

  23. Creasman WT, Fetter BF, Clarke-Pearson DL, et al. (1985) Management of stage IA carcinoma of the cervix. Am J Obstet Gynecol 153:164–172.

    PubMed  CAS  Google Scholar 

  24. Morrow CP, Townsend DE (1987) Synopsis of Gynecologic Oncology, 3rd ed. New York: John Wiley & Sons, p. 117.

    Google Scholar 

  25. Delgado G, Bundy B, Zaino R, et al. (1990) Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study. Gynecol Oncol 38:352–357.

    Article  PubMed  CAS  Google Scholar 

  26. Tinga DJ, Timmer PR, Bouma J, et al. (1990) Prognostic significance of single versus multiple lymph node metastases in cervical carcinoma stage IB. Gynecol Oncol 39:175–180.

    Article  PubMed  CAS  Google Scholar 

  27. Kamura T, Tsukamoto N, Tsuruchi N, et al. (1992) Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer 69:181–186.

    Article  PubMed  CAS  Google Scholar 

  28. Berman ML, Keys H, Creasman W, et al. (1984) Survical and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes. Gynecol Oncol 19:8–16.

    Article  PubMed  CAS  Google Scholar 

  29. Buchsbaum HJ (1979) Extrapelvic lymph node metastases in cervical carcinoma. Am J Obstet Gynecol 133:814–821.

    PubMed  CAS  Google Scholar 

  30. Averette HE, Donato DM, Lovecchio JL, Sevin BU (1987) Surgical staging of gynecologic malignancies. Cancer 60:2010–2020.

    Article  PubMed  CAS  Google Scholar 

  31. Twiggs LB, Potish RA, George RJ, Adcock LL (1984) Pretreatment extraperitoneal surgical staging in primary carcinoma of the cervix uteri. Surg Gynecol Obstet 158:243–250.

    PubMed  CAS  Google Scholar 

  32. Gallup DG, Jordan GH, Talledo OE (1986) Extraperitoneal lymph node dissections with use of a midline incision in patients with female genital cancer. Am J Obstet Gynecol 155:559–564.

    PubMed  CAS  Google Scholar 

  33. Ballon SC, Berman ML, Lagasse LD, et al. (1981) Survival after paraaortic lymphadenectomy and radiation therapy in cervical cancer. Obstet Gynecol 57:90.

    PubMed  CAS  Google Scholar 

  34. Coleman DL, Gallup DG, Wolcott HD, et al. (1992) Patterns of failure of bulky-barrel carcinomas of the cervix. Am J Obstet Gynecol 166:916.

    PubMed  CAS  Google Scholar 

  35. Tulzer H, Kupka S (1978) The effectiveness of obligatory lymphadenectomy in treating carcinoma of the cervix. Int J Gynaecol Obstet 16:197–203.

    PubMed  Google Scholar 

  36. Kjorstad KE, Kolbenstvedt A, Strickert T (1984) The value of complete lymphadenectomy in radical treatment of cancer of the cervix, stage IB. Cancer 54:2215–2219.

    Article  PubMed  CAS  Google Scholar 

  37. Inoue T, Chihara T, Morita K (1984) The prognostic significance of the size of the largest nodes in metastatic carcinoma from the uterine cervix. Gynecol Oncol 19:187–193.

    Article  PubMed  CAS  Google Scholar 

  38. Lagasse LD, Smith ML, Moore JG, et al. (1974) The effect of radiation therapy on pelvic lymph node involvement in stage I carcinoma of the cervix. Am J Obstet Gynecol 119:328–334.

    PubMed  CAS  Google Scholar 

  39. Vigliotti AP, Wen BC, Hussey DH, et al. (1992) Extended field irradiation for carcinoma of the uterine cervix with positive periaortic nodes. Int J Radiat Oncol Biol Phys 23:501–509.

    Article  PubMed  CAS  Google Scholar 

  40. Keys H, Park RC (1976) Treatment and survival of patients with cancer of the cervix and nodal metastases. Int J Radiat Oncol Biol Phys 11:1091–1097.

    Article  Google Scholar 

  41. Potish RA, Downey GO, Adcock LL, Prem KA, Twiggs LB (1989) The role of surgical debulking in cancer of the uterine cervix. Int J Radiat Oncol Biol Phys 17:979–984.

    Article  PubMed  CAS  Google Scholar 

  42. Hacker NF, Wain GV, Nickiin JL (1995) Resection of bulky positive lymph nodes in patients with cervical carcinoma. Int J Gynecol Cancer 5:250–256.

    Article  PubMed  Google Scholar 

  43. Averette HE, Jobson VW (1979) The role of exploratory laparotomy in the staging and treatment of invasive cervical carcinoma. Int J Radiat Oncol Biol Phys 5:2137–2138.

    Article  PubMed  CAS  Google Scholar 

  44. Heller PB, Malfetano JH, Bundy BN, et al. (1990) Clinical-pathologic study of stage II-B, III, and IV-A carcinoma of the cervix: Extended diagnostic evaluation for para-aortic node metastasis — A Gynecologic Oncology Group study. Gynecol Oncol 38:425–430.

    Article  PubMed  CAS  Google Scholar 

  45. Stehman FB, Bundy BN, DiSaia PJ, et al. (1991) Carcinoma of the cervix treated with radiation therapy I: A multivariate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 67:2776–2785.

    Article  PubMed  CAS  Google Scholar 

  46. Averette HE, Donato DM, Lovecchio JL, et al. (1987) Surgical staging of gynecologic malignancies. Cancer 60:2010–2020.

    Article  PubMed  CAS  Google Scholar 

  47. Priver MS, Barlow JJ (1974) Para-aortic lymphadenectomy in staging patients with advanced local cervical cancer. Obstet Gynecol 43:544–548.

    Google Scholar 

  48. Wharton JT, Jones HW, Day TG, et al. (1977) Preirradiation celiotomy and extended field irradiation for invasive carcinoma of the cervix. Obstet Gynecol 49:333–338.

    PubMed  CAS  Google Scholar 

  49. Delgado G, Caglar H, Walker P (1978) Survival and complications in cervical cancer treated by pelvic and extended field radiation after para-aortic lymphadenectomy. Am J Roentgenol 130:141–143.

    CAS  Google Scholar 

  50. Schellhas HF (1975) Extraperitoneal para-aortic node dissection through an upper abdominal incision. Obstet Gynecol 46:444–447.

    PubMed  CAS  Google Scholar 

  51. Gallup DG, Jordan GH, Talledo OE (1986) Extraperitoneal lymph node dissections with use of a midline incision in patients with female genital cancer. Am J Obstet Gynecol 155:559–564.

    PubMed  CAS  Google Scholar 

  52. Weiser EB, Bundy BN, Hoskins WJ, et al. (1989) Extraperitoneal versus transperitoneal selective paraaortic lymphadenectomy in the pretreatment surgical staging of advanced cervical carcinoma. A Gynecologic Oncology Group study. Gynecol Oncol 33:283–289.

    CAS  Google Scholar 

  53. Fowler J, Carter J, Carlson J, Maslonkowski R, Byers L, Carson L, Twiggs L (1993) Lymph node yield from laparoscopic lymphadenectomy in cervical cancer: A comparative study. Gynecol Oncol 51:187–192.

    Article  PubMed  CAS  Google Scholar 

  54. Querleu D, LeBlanc E, Castelain B (1991) Laparoscopic pelvic lymphadenectomy in the staging of early carcinoma of the cervix. Am J Obstet Gynecol 164:579–581.

    PubMed  CAS  Google Scholar 

  55. Childers J, Hatch K, Surwit E (1992) The role of laparoscopic lymphadenectomy in the management of cervical carcinoma. Gynecol Oncol 47:38–43.

    Article  PubMed  CAS  Google Scholar 

  56. Hallum AV, Hatch KD, Nour M, Childers J, Surwit E (1996) Laparoscopic radical vaginal hysterectomy (Schauta) and nodal dissection (abstr). Gynecol Oncol 60:118.

    Google Scholar 

  57. Dargent D (1993) Laparoscopic surgery and gynecologic cancer. Curr Opin Obstet Gynecol 5:294–300.

    Article  PubMed  CAS  Google Scholar 

  58. Roy M, Plante M, Renaud MC, Tetu B (1996) Vaginal radical surgery in the treatment of early-stage cervical cancer (abstr). Gynecol Oncol 60:100.

    Google Scholar 

  59. Durrance FY, Fletcher GH, Rutledge FN (1969) Analysis of central recurrent disease in stages I and II squamous cell carcinomas of the cervix on intact uterus. Am J Roentgenol 106:831–838.

    CAS  Google Scholar 

  60. Gallion HH, Van Nagell JR Jr., Donaldson ES, et al. (1985) Combined radiation therapy and extrafascial hysterectomy in the treatment of stage IB barrel-shaped cervical cancer. Cancer 56:262–265.

    Article  PubMed  CAS  Google Scholar 

  61. Mendenhall WM, McCarty PJ, Morgan LS, Chafe WE, Million RR (1991) Stage IB-IIA-B carcinoma of the intact uterine cervix greater than or equal to 6 cm in diameter: Is adjuvant extrafascial hysterectomy beneficial?. Int J Radiat Oncol Biol Phys 21:899–904.

    Article  PubMed  CAS  Google Scholar 

  62. Eifel PJ, Morris M, Wharton JT, Oswald MJ (1994) The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 29:9–16.

    Article  PubMed  CAS  Google Scholar 

  63. Moore DH (1996) Anatomy, natural history, and patterns of spread of invasive cervical cancer. In: Rubin SC, Hoskins WJ, eds. Cervical Cancer and Preinvasive Neoplasia. New York: Lippincott-Raven, pp. 161–170.

    Google Scholar 

  64. Morris M (1994) Microinvasive cancer of the cervix. Clin Consult Obstet Gynecol 6:54–61.

    Google Scholar 

  65. Simon N, Gore H, Shingleton H (1986) Study of superficially invasive squamous cell carcinoma of the cervix. Obstet Gynecol 68:19–23.

    PubMed  CAS  Google Scholar 

  66. Anderson E, Husth M, Joerjenson A, et al. (1993) Laser conization for microinvasive carcinoma of the cervix: Short-term results. Int J Gynecol Cancer 3:1283–1285.

    Google Scholar 

  67. Morris M, Folien Mitchell M, Silva EG, et al. (1993) Cervical conization as definitive therapy for early invasive squamous carcinoma of the cervix. Gynecol Oncol 51:193–196.

    Article  PubMed  CAS  Google Scholar 

  68. Kolstad P (1988) Follow-up study of 232 patients with stage Ial and 411 patients with stage Ia2 squamous cell carcinoma of the cervix (microinvasive carcinoma). Gynecol Oncol 33:265–272.

    Article  Google Scholar 

  69. Dargent D, Brun JL, Roy M, Remy I (1994) Pregnancies following radical trachelectomy for invasive cervical cancer (abstr). Gynecol Oncol 52:105.

    Google Scholar 

  70. Rontgen WC (1885) Eine neue arte von Strahlen. In: Proceedings of the Wurzburg Physico-Medical Society; December Wurzburg, Germany, no. 137.

    Google Scholar 

  71. (1896) Local action of the x-ray. JAMA 27:1254.

    Google Scholar 

  72. Perez CA (1993) Radiation therapy in the management of cancer of the cervix. Part 1. Oncology 7:89–96.

    PubMed  CAS  Google Scholar 

  73. Montana GS, Fowler WC, Varia MA, Walton LA, Mack Y (1987) Analysis of results of radiation therapy for stage IB carcinoma of the cervix. Cancer 60:2195–2200.

    Article  PubMed  CAS  Google Scholar 

  74. Montana GS, Fowler WC, Varia MA, Walton LA, Mack Y (1985) Analysis of results of radiation therapy for stage II carcinoma of the cervix. Cancer 55:956–962.

    Article  PubMed  CAS  Google Scholar 

  75. Montana GS, Fowler WC, Varia MA, Walton LA, Mack Y, Shemanski L (1986) Carcinoma of the cervix, stage III: Results of radiation therapy. Cancer 57:148–154.

    Article  PubMed  CAS  Google Scholar 

  76. Perez CA (1993) Radiation therapy in the management of cancer of the cervix. Part 2. Oncology 7:61–69.

    PubMed  CAS  Google Scholar 

  77. Komaki R, Brickner TJ, Hanson AL, Owen JB, Hanks GE (1995) Long-term results of treatment of cervical carcinoma in the United States in 1973,1978, and 1983: Patterns of Care Study (PCS). Int J Radiat Oncol Biol Phys 31:973–982.

    Article  PubMed  CAS  Google Scholar 

  78. Montana GS, Hanlon AL, Brickner TJ, et al. (1995) Carcinoma of the cervix: Patterns of Care Studies: Review of 1978, 1983, and 1988-1989 surveys. Int J Radiat Oncol Biol Phys 32:1481–1486.

    Article  PubMed  CAS  Google Scholar 

  79. Stehman FB, Thomas GM (1994) Prognostic factors in locally advanced carcinoma of the cervix treated with radiation therapy. Semin Oncol 21:25–29.

    PubMed  CAS  Google Scholar 

  80. Kucera H, Enzelsberger H, Eppel W, Weghaupt K (1987) The influence of nicotine abuse and diabetes mellitus on the results of primary irradiation in the treatment of carcinoma of the cervix. Cancer 60:1–4.

    Article  PubMed  CAS  Google Scholar 

  81. Kim RY, McGinnis LS, Spencer SA, Meredith RF, Jennelle RLS, Salter MM (1995) Conventional four-field pelvic radiotherapy technique without computed tomography — treatment planning in cancer of the cervix: Potential geographic miss and its impact on pelvic control. Int J Radiat Oncol Biol Phys 31:109–112.

    Article  PubMed  CAS  Google Scholar 

  82. Brizel DM, Rosner GL, Prosnitz LR, Dewhirst MW (1995) Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas, and lymph node metastases. Int J Radiat Oncol Biol Phys 32:1121–1125.

    Article  PubMed  CAS  Google Scholar 

  83. Tsang RW, Fyles AW, Kirkbride P, et al. (1995) Proliferation measurements with flow cytometry Tpol in cancer of the uterine cervix: Correlation between two laboratories and preliminary clinical results. Int J Radiat Oncol Biol Phys 32:1319–1329.

    Article  PubMed  CAS  Google Scholar 

  84. Wheeler JA, Stephens LC, Tornos C, et al. (1995) ASTRO Research Fellowship: Apoptosis as a predictor of tumor response to radiation in stage IB cervical carcinoma. Int J Radiat Oncol Biol Phys 32:1487–1493.

    Article  PubMed  CAS  Google Scholar 

  85. Fu KK (1985) Biological basis for the interaction of chemotherapeutic agents and radiation therapy. Cancer 55:2123–2130.

    Article  PubMed  CAS  Google Scholar 

  86. Sinclair WK (1967) Hydroxyurea: Effects on Chinese hamster cells grown in culture. Cancer Res 27:297–308.

    PubMed  CAS  Google Scholar 

  87. Phillips RA, Tolmach LJ (1966) Repair of potentially lethal damage in x-irradiated HeLa cells. Radiat Res 29:413–432.

    Article  PubMed  CAS  Google Scholar 

  88. Piver MS, Barlow JJ, Vongtama V, Blumenson L (1983) Hydroxyurea: A radiation potentiator in carcinoma of the uterine cervix. Am J Obstet Gynecol 147:803–808.

    PubMed  CAS  Google Scholar 

  89. Piver MS, Krishnamsetty RM, Emrich LJ (1985) Survival of nonsurgically staged patients with negative lymphangiograms who had stage IIB carcinoma of the cervix treated by pelvic radiation plus hydroxyurea. Am J Obstet Gynecol 151:1006–1008.

    PubMed  CAS  Google Scholar 

  90. Hreshchyshyn MM, Aron BS, Boronow RC, Franklin EW, Shingleton HM, Blessing JA (1979) Hydroxyurea or placebo combined with radiation to treat stages IIIB and IV cervical cancer confined to the pelvis. Int J Radiat Oncol Biol Phys 5:317–322.

    Article  PubMed  CAS  Google Scholar 

  91. Hall EJ, Astor MA, Biaglow J, et al. (1982) The enhanced sensitivity of mammalian cells to killing by x-rays after prolonged exposure to several nitroimidazoles. Int J Radiat Oncol Biol Phys 8:447–451.

    Article  PubMed  CAS  Google Scholar 

  92. Stehman FB, Bundy BN, Keys H, Currie JL, Mortel R, Creasman WT (1988) A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix. Am J Obstet Gynecol 159:87–94.

    PubMed  CAS  Google Scholar 

  93. Stehman FB, Bundy BN, Thomas G, et al. (1993) Hydroxyurea versus misonidazole with radiation in cervical carcinoma: Long-term follow-up of a Gynecologic Oncology Group trial. J Clin Oncol 11:1523–1528.

    PubMed  CAS  Google Scholar 

  94. Dische S, Chassagne D, Machin D (1991) Randomized controlled trial of the use of pimonidazole (Ro 03 8799) in the treatment of advanced carcinoma of the cervix. Seventh International Conference on Chemical Modifiers of Cancer Treatment, Clearwater, Florida, pp.172-173.

    Google Scholar 

  95. Leibel S, Bauer M, Wasserman T, et al. (1987) Radiotherapy with or without misonidazole for patients with stage IIIB or stage IVA squamous cell carcinoma of the uterine cervix: Preliminary report of a Radiation Therapy Oncology Group randomized trial. Int J Radiat Oncol Biol Phys 13:541–549.

    Article  PubMed  CAS  Google Scholar 

  96. Butler J, Hoey BM, Swallow AJ (1985) The radiation chemistry of some platinum-containing radiosensitizers and related compounds. Radiat Res 102:1–13.

    Article  PubMed  CAS  Google Scholar 

  97. Nias AHW (1985) Radiation and platinum drug interactions. Int J Radiat Biol 48:297–314.

    Article  CAS  Google Scholar 

  98. Begg AC, Van Der Kolk PJ, Dewit L, Bartelink H (1986) Radiosensitization by cisplatin of RIF1 tumour cells in vitro. Int J Radiat Biol 50:871–884.

    Article  CAS  Google Scholar 

  99. Britten RA, Evans AJ, Allalunis-Turner MJ, Pearcey RG (1996) Effect of cisplatin on the clinically relevant radiosensitivity of human cervical carcinoma cell lines. Int J Radiat Oncol Biol Phys 34:367–374.

    Article  PubMed  CAS  Google Scholar 

  100. Potish R, Twiggs L, Adcock L, Savage J, Prem K, Levitt S (1986) Effect of cisplatinum on tolerance to radiation therapy in advanced cervical cancer. Am J Clin Oncol 9:387–391.

    Article  PubMed  CAS  Google Scholar 

  101. Malfetano J, Keys H, Kredentser D, Cunningham M, Kotlove D, Weiss L (1993) Weekly cisplatin and radical radiation therapy for advanced, recurrent, and poor prognosis cervical carcinoma. Cancer 71:3703–3706.

    Article  PubMed  CAS  Google Scholar 

  102. Runowicz CD, Wadler S, Rodriguez-Rodriguez L, et al. (1980) Concomitant cisplatin and radiotherapy in locally advanced cervical carcinoma. Gynecol Oncol 34:395–401.

    Article  Google Scholar 

  103. Choo YC, Choy TK, Wong LC, Ma HK (1986) Potentiation of radiotherapy by cisdichlorodiammine platinum (II) in advanced cervical carcinoma. Gynecol Oncol 23:94–100.

    Article  PubMed  CAS  Google Scholar 

  104. Berry RJ (1966) Effects of some metabolic inhibitors on x-ray dose-response curves for the survival of mammalian cells in vitro, and on early recovery between fractionated x-ray doses. Br J Radiol 39:458–463.

    Article  PubMed  CAS  Google Scholar 

  105. Byfield JE, Calabro-Jones P, Klisak I, Kulhanian F (1982) Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and x rays. Int J Radiat Oncol Biol Phys 8:1923–1933.

    Article  PubMed  CAS  Google Scholar 

  106. Kennedy KA, Rockwell S, Sartorelli AC (1980) Enhancement of mitomycin-C cytotoxic metabolites by hypoxic tumor cells. Cancer Res 40:2356–2360.

    PubMed  CAS  Google Scholar 

  107. Thomas G, Dembo A, Fyles A, et al. (1990) Concurrent chemoradiation in advanced cervical cancer. Gynecol Oncol 38:446–451.

    Article  PubMed  CAS  Google Scholar 

  108. Husseinzadeh N, Shrake P, DeEulis T, Rowley K, Aron B (1994) Chemotherapy and extended-field radiation therapy to para-aortic area in patients with histologically proven metastatic cervical cancer to para-aortic nodes: A phase II pilot study. Gynecol Oncol 52:326–331.

    Article  PubMed  CAS  Google Scholar 

  109. Park TK, Lee SK, Kim SN, et al. (1993) Combined chemotherapy and radiation for bulky stages I–II cervical cancer: Comparison of concurrent and sequential regimens. Gynecol Oncol 50:196–201.

    Article  PubMed  CAS  Google Scholar 

  110. Heaton D, Yordan E, Reddy S, et al. (1990) Treatment of 29 patients with bulky squamous cell carcinoma of the cervix with simultaneous cisplatin, 5-fluorouracil, and split-course hyperfractionated radiation therapy. Gynecol Oncol 38:323–327.

    Article  PubMed  CAS  Google Scholar 

  111. Mickiewicz E, Roth B, Alvarez A, et al. (1991) Chemotherapy (CT)2 plus radiotherapy (RT) vs. radiotherapy alone in cervical cancer stage IIab to IVa: A randomized study (abstr). Proc Am Soc Clin Oncol 10:192.

    Google Scholar 

  112. Geard CR, Jones JM, Schiff PB (1993) Taxol and radiation. Monogr Natl Cancer Inst 15:89–94.

    PubMed  Google Scholar 

  113. Mattern MR, Hofmann GA, McCabe EL, Johnson RK (1991) Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK & F 104864). Cancer Res 51:5813–5816.

    PubMed  CAS  Google Scholar 

  114. O’Connel D, Howard N, Joslin CAF, Ramsey NW, Liversage WE (1965) A new remotely controlled unit for the treatment of uterine carcinoma. Lancet 18:570–571.

    Article  Google Scholar 

  115. Arai T, Nakano T, Morita S, Sakashita K, Nakamura YK, Fukuhisa K (1992) High-dose-rate remote afterloading intracavitary radiation therapy for cancer of the uterine cervix: A 20-year experience. Cancer 69:175–180.

    Article  PubMed  CAS  Google Scholar 

  116. Hsu WL, Wu CJ, Jen YM, et al. (1995) Twice-per-day fractionated high versus continuous low dose rate intracavitary therapy in the radical treatment of cervical cancer: A nonrandomized comparison of treatment results. Int J Radiat Oncol Biol Phys 32:1425–1431.

    Article  PubMed  CAS  Google Scholar 

  117. Fu KK, Phillips TL (1990) High-dose-rate versus low-dose-rate intracavitary brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 19:791–796.

    Article  PubMed  CAS  Google Scholar 

  118. Patel FD, Sharma SC, Pritam SN, Ghoshal S, Gupta BD (1993) Low dose rate versus high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: A clinical trial. Int J Radiat Oncol Biol Phys 28:335–341.

    Article  Google Scholar 

  119. Lee KH, Kagan AR, Nussbaum H, et al. (1976) Analysis of dose, dose-rate and treatment time in the production of injuries by radium treatment for cancer of the uterine cervix. Br J Radiol 49:430–440.

    Article  PubMed  CAS  Google Scholar 

  120. Haie-Meder C, Kramar A, Lambin P, et al. (1994) Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinoma. Int J Radiat Oncol Biol Phys 29:953–960.

    Article  PubMed  CAS  Google Scholar 

  121. Eifel PJ, Levenback C, Wharton JT, Oswald MJ (1995) Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 32:1289–1300.

    Article  PubMed  CAS  Google Scholar 

  122. Orton CG, Seyedsadr M, Somany A (1991) Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation. Int J Radiat Oncol Biol Phys 21:1425–1434.

    Article  PubMed  CAS  Google Scholar 

  123. (1980) Is pelvic radiation beneficial in the postoperative management of stage Ib squamous cell carcinoma of the cervix with pelvic node metastasis treated by radical hysterectomy and pelvic lymphadenectomy? Gynecol Oncol 10:105-110.

    Google Scholar 

  124. Hogan WM, Littman P, Griner L, Miller CL, Mikuta JJ (1982) Results of radiation therapy given after radical hysterectomy. Cancer 49:1278–1285.

    Article  PubMed  CAS  Google Scholar 

  125. Larson DM, Stringer CA, Copeland LJ, Gershenson DM, Malone JM, Rutledge FN (1987) Stage IB cervical carcinoma treated with radical hysterectomy and pelvic lymphadenectomy: Role of adjuvant radiotherapy. Obstet Gynecol 69:378–381.

    PubMed  CAS  Google Scholar 

  126. Stock RG, Chen ASJ, Flickinger JC, Kainicki S, Seski J (1995) Node-positive cervical cancer: Impact of pelvic irradiation and patterns of failure. Int J Radiat Oncol Biol Phys 31:31–36.

    Article  PubMed  CAS  Google Scholar 

  127. Thomas GM, Stehman FB (1994) Early invasive disease: Risk assessment and management. Semin Oncol 21:17–24.

    PubMed  CAS  Google Scholar 

  128. Tattersall MHN, Ramirez C, Coppleson M (1992) A randomized trial of adjuvant chemotherapy after radical hysterectomy in stage Ib-IIa cervical cancer patients with pelvic lymph node metastases. Gynecol Oncol 46:176–181.

    Article  PubMed  CAS  Google Scholar 

  129. Killackey MA, Boardman L, Carroll DS (1993) Adjuvant chemotherapy and radiation in patients with poor prognostic stage Ib/IIa cervical cancer. Gynecol Oncol 49:377–379.

    Article  PubMed  CAS  Google Scholar 

  130. Friedlender ML, Atkinson K, Coppleson JVM, et al. (1984) The integration of chemotherapy into the management of locally advanced cervical cancer: A pilot study. Gynecol Oncol 19:1–7.

    Article  Google Scholar 

  131. Kim DS, Moon H, Kim KT, et al. (1989) Two-year survival: Preoperative adjuvant chemotherapy in the treatment of cervical cancer stages Ib and II with bulky tumor. Gynecol Oncol 33:225–230.

    Article  PubMed  CAS  Google Scholar 

  132. Sardi J, Sananas C, Giaroli A, et al. (1990) Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri. Gynecol Oncol 38:486–493.

    Article  PubMed  CAS  Google Scholar 

  133. Rabinovich MG, Focaccia G, Ferreyra R, et al. (1991) Neoadjuvant chemotherapy for cervical carcinoma. Obstet Gynecol 78:685–688.

    PubMed  CAS  Google Scholar 

  134. Weiner SA, Artistizabal S, Alberts DS, et al. (1988) A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma. Gynecol Oncol 30:1–6.

    Article  PubMed  CAS  Google Scholar 

  135. Lipsztein R, Kredentser D, Dottino P, et al. (1987) Combined chemotherapy and radiation therapy for advanced carcinoma of the cervix. Am J Clin Oncol 10:527.

    Article  PubMed  CAS  Google Scholar 

  136. Park TK, Chol DH, Dim SN, et al. (1991) Role of induction chemotherapy in invasive cervical cancer. Gynecol Oncol 41:107–112.

    Article  PubMed  CAS  Google Scholar 

  137. Souhami L, Gil RA, Allan SE, et al. (1991) A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix. J Clin Oncol 9:970–977.

    PubMed  CAS  Google Scholar 

  138. Chauvergne J, Rohart J, Heron JF, et al. (1988) Randomized phase III trial of neoadjuvant chemotherapy (CT) + radiotherapy (RT) vs. RT in stage IIB, III carcinoma of the cervix (CACX): A cooperative study of the French oncology centers (abstr). Proc Am Soc Clin Oncol 7:136.

    Google Scholar 

  139. Tattersall MHN, Ramirez C, Coppleson M (1992) A randomized trial comparing platinum-based chemotherapy followed by radiotherapy vs. radiotherapy alone in patients with locally advanced cervical cancer. Int J Gynecol Cancer 2:244–251.

    Article  PubMed  Google Scholar 

  140. Sundfor K, Trope CG, Hogberg T, et al. (1996) Radiotherapy and neoadjuvant chemotherapy for cervical cancer: A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A. Cancer 77:2371–2378.

    Article  PubMed  CAS  Google Scholar 

  141. Sardi J, Sananes C, Giaroli A, et al. (1993) Results of a prospective randomized trial with neoadjuvant chemotherapy in stage IB, bulky, squamous carcinoma of the cervix. Gynecol Oncol 49:156–165.

    Article  PubMed  CAS  Google Scholar 

  142. Omura GA (1992) Current status of chemotherapy for cancer of the cervix. Oncology 6:27–32.

    PubMed  CAS  Google Scholar 

  143. Thigpen JT, Shingleton H, Homesley H, et al. (1981) cis-Platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: A phase II trial of the Gynecologic Oncology Group. Cancer 48:899–903.

    Article  PubMed  CAS  Google Scholar 

  144. Bonomi P, Blessing J, Stehman FB, et al. (1985) Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix — A Gynecologic Oncology Group study. J Clin Oncol 3:1079–1085.

    PubMed  CAS  Google Scholar 

  145. Thigpen JT, Blessing JA, DiSaia PJ, Fowler WC, Hatch KD (1989) A randomized comparison of rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: A Gynecologic Oncology Group study. Gynecol Oncol 32:198–202.

    Article  PubMed  CAS  Google Scholar 

  146. McGuire WP, Arseneau JC, Blessing JA, et al. (1989) A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix — A Gynecologic Oncology Group study. J Clin Oncol 7:1462–1468.

    PubMed  Google Scholar 

  147. Stehman FB, Blessing JA, McGehee R, et al. (1989) A phase II evaluation of mitolactol in carcinoma of the cervix. J Clin Oncol 7:1892–1895.

    PubMed  CAS  Google Scholar 

  148. Coleman RE, Harper PG, Gallagher C, et al. (1986) A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervix. Cancer Chemother Pharmacol 18:280–283.

    Article  PubMed  CAS  Google Scholar 

  149. Meanwell CA, Mould JJ, Blackledge G, et al. (1986) Phase II study of ifosfamide in cervical cancer. Cancer Treat Rep 70:727–730.

    PubMed  CAS  Google Scholar 

  150. Sutton GP, Blessing JA, McGuire WP, Patton T, Look KY (1993) Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: A Gynecologic Oncology Group study. Am J Obstet Gynecol 168:805–807.

    PubMed  CAS  Google Scholar 

  151. Omura GA, Blessing J, Vaccarello L, Berman M, Mutch D, Clarke-Pearson D, Anderson B (199··) A randomized trial of cisplatin versis cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: A Gynecologic Oncology Group study. J Clin Oncol, in press.

    Google Scholar 

  152. McGuire WP, Blessing JA, Moore DH, Lentz SS, Photopulos G (1996) Paclitaxel has moderate activity in squamous cervix cancer: A Gynecologic Oncology Group study. J Clin Oncol 14:792–795.

    PubMed  CAS  Google Scholar 

  153. Murphy WK, Fossella FV, Winn RJ, et al. (1993) Phase II study of taxol in patients with untreated advanced non-small cell lung cancer. J Natl Cancer Inst 85:384–388.

    Article  PubMed  CAS  Google Scholar 

  154. Forastiere AA, Neuberg D, Taylor SG, et al. (1993) Phase II study of taxol in advanced head and neck cancer: An Eastern Cooperative Oncology Group trial. JNCI Monogr 15:181–184.

    Google Scholar 

  155. Hsiang YH, Hertzberg R, Hecht S, et al. (1985) Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 260:14873–14878.

    PubMed  CAS  Google Scholar 

  156. Kavanagh JJ, Kudelka AP, Edwards CE, et al. (1994) CPT-11 (Irinotecan): Phase II trial in refractory squamous cell carcinoma of the cervix (abstr). Proc AACR 35: 234.

    Google Scholar 

  157. Noda K, Sasaki H, Yamamoto K, et al. (1996) Phase II trial of topotecan for cervical cancer of the uterus (abstr). Proc Am Soc Clin Oncol 15:280.

    Google Scholar 

  158. Itoh K, Takada M, Kudo S, et al. (1991) Synergistic effects of CPT-11 and cisplatin or etoposide on human lung cancer cell lines demonstrated by computer analysis (abstr). Lung Cancer 7:124.

    Google Scholar 

  159. Johnson RK, McCabe FL, Yu Y (1992) Combination regimens with topotecan in animal tumor models (abstr). Ann Oncol 3:85.

    Article  Google Scholar 

  160. Masuda N, Fukuoda M, Takada M, et al. (1992) CPT-11 in combination with cisplatin for advanced non-small cell lung cancer. J Clin Oncol 10:1775–1780.

    PubMed  CAS  Google Scholar 

  161. Miller AA, Hargis JB, Lilenbaum RC, Fields SZ, Rosner GL, Schilsky RL (1994) Phase I study of topotecan and cisplatin in patients with advanced solid tumors: A Cancer and Leukemia Group B study. J Clin Oncol 12:2743–2750.

    PubMed  CAS  Google Scholar 

  162. Hovanessian A (1991) Interferon-induced and double-stranded RNA-activated enzymes: A specific protein kinase and 2′-5′ oligoadenylate synthetases. J Interferon Res 11:199–205.

    Article  PubMed  CAS  Google Scholar 

  163. Meyskens FL Jr., Goodman Ge, Alberts DS (1985) 13-Cis-retinoic acid: Pharmacology, toxicology, and clinical applications for the prevention and treatment of human cancer. Crit Rev Oncol Hematol 3:75–101.

    Article  PubMed  Google Scholar 

  164. Lippman SM, Kavanagh JJ, Paredes-Espinoza M, et al. (1992) 13-Cis-retinoic acid plus interferon alpha-2a: Highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst 84:241–245.

    Article  PubMed  CAS  Google Scholar 

  165. Murad AM, Oliveira M, Saldanha TM (1994) Phase II trial of isotretinoin and interferon α-2a in the treatment of advanced recurrent cervical carcinoma. Int J Gynecol Cancer 4:414–418.

    Article  PubMed  Google Scholar 

  166. Hallum AV, Alberts DS, Lippman SM, et al. (1995) Phase II study of 13-cis-retinoic acid plus interferon-alpha 2a in heavily pretreated squamous carcinoma of the cervix. Gynecol Oncol 56:382–386.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. David H. Moore
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA

    Robert F. Ozols M.D., Ph.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Moore, D.H. (1998). Advances in the treatment of cervical cancer. In: Ozols, R.F. (eds) Gynecologic Oncology. Cancer Treatment and Research, vol 95. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5447-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-5447-9_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7487-9

  • Online ISBN: 978-1-4615-5447-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation